Dorman’s Analyst Bullishness Clashes With Lagging Growth

Forward-Looking Analysis

Wall Street analysts maintain a "Strong Buy" consensus for Dorman Products, with four of five analysts rating the stock as a Strong Buy and one as a Buy. The average 12-month price target stands at $147.00, representing a potential upside of 19.74% from the current price of $122.77. The highest forecast is $155.00, while the minimum is $140.00. For fiscal year 2026, analysts project revenue to reach $2.3 billion, reflecting an 8.58% growth rate. Net income is forecast at approximately $252.2 million, with a range between $237.2 million and $263.6 million. Earnings per share (EPS) are expected to be $8.44, up 35.27% from prior periods, with estimates ranging from $7.94 to $8.82. Despite these positive projections, DORM’s forecast earnings growth rate of 18.69% lags behind the US Auto Parts industry average of 38.48% and the broader US market’s 34.13%. Similarly, revenue growth of 6.64% trails the industry’s 9.44% and market’s 13.92%. However, efficiency metrics remain strong, with a forecast Return on Assets (ROA) of 12.75%, surpassing the industry average of 11.83%, and a Return on Equity (ROE) of 21.18%.

Historical Performance Review

In the first quarter of 2026, Dorman Products reported revenue of $528.77 million, generating a gross profit of $190.16 million. The company achieved a net income of $43.55 million, resulting in an EPS of $1.44. These Q1 figures establish a baseline for the year, though analysts project significantly higher full-year earnings of $8.44 EPS and $2.3 billion in revenue for 2026, indicating expected acceleration in subsequent quarters.

Additional News

Recent data indicates that Dorman Products (NASDAQ: DORM) is currently trading at $122.77. The stock has attracted significant attention from financial analysts, with a quant model from WallStreetZen assigning it a "Hold" rating, citing an average historical return of +7.53% per year for stocks with this specific rating. This contrasts with the consensus "Strong Buy" from traditional analysts. No specific news regarding new product launches, mergers and acquisitions, or executive changes was identified in the provided source material. The primary recent activity involves analyst revisions and price target adjustments, with the next major price target update expected by May 4, 2027.

Summary & Outlook

Dorman Products demonstrates solid financial health with strong efficiency metrics, including an ROA of 12.75% and ROE of 21.18%, outperforming industry averages. However, growth catalysts are mixed; while EPS and revenue are forecast to grow significantly in 2026, the company’s growth rates trail both its sector and the broader market. The primary upside driver is the bullish analyst sentiment, with a 19.74% upside to the average price target of $147.00. Despite lagging growth relative to peers, the strong buy consensus and robust profitability metrics support a cautiously optimistic stance. The outlook remains positive for income efficiency but neutral regarding competitive growth momentum.